Furthermore, high EREG and AREG expression was recently reported to correlate with longer progression-free and overall survival in a retrospective series of patients with recurrent/metastatic HNSCC treated with Cetuximab and chemotherapy [47]. This evidence concerns the gene EREG and head and neck squamous cell carcinoma.